.
MergerLinks Header Logo

Announced

EVERSANA to acquire Cornerstone Research Group.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Knowledge Process Outsourcing

Pending

market research

Private

Canada

Majority

Acquisition

Single Bidder

Friendly

Synopsis

Edit

EVERSANA, a provider of commercial services to the life science industry, agreed to acquire Cornerstone Research Group, a global health economic and market access research company supporting pharmaceutical and medical device companies. Financial terms were not disclosed. "Pharmaceutical companies face strong pressures to quickly assess and quantify both the direct and indirect value of their in-market products and development pipeline. By adding a strong health economics and outcomes capability to our integrated commercial platform, we can now conceptualize, deliver and measure value at every stage of the product lifecycle from clinical trials to ongoing patient adherence. The Cornerstone Research Group team brings tremendous expertise that will deliver immediate value to our clients worldwide, and we're thrilled to have them on board," Jim Lang, CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US